Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
Source: Critical Care - Category: Intensive Care Authors: Guillermo Rodriguez-Nava, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Chul Won Chung, Valeria Patricia Trelles-Garcia and Harvey J. Friedman Tags: Research Letter Source Type: research
More News: Atorvastatin Calcium | COVID-19 | Intensive Care | Lipitor | Statin Therapy | Study | Zivast